100XBIO

About 100XBIO

The company specializes in T-cell antigen specificity and sequencing analysis through proprietary technology that enhances the understanding of T-cell receptor diversity. This capability is crucial for advancing immunology research, immunotherapy development, and improving disease diagnosis and treatment outcomes.

What does 100XBIO do?

The company specializes in T-cell antigen specificity and sequencing analysis through proprietary technology that enhances the understanding of T-cell receptor diversity. This capability is crucial for advancing immunology research, immunotherapy development, and improving disease diagnosis and treatment outcomes.

Where is 100XBIO located?

100XBIO is based in Woburn, Canada.

When was 100XBIO founded?

100XBIO was founded in 2023.

Who founded 100XBIO?

100XBIO was founded by Sergei Pustylnikov.

  • Sergei Pustylnikov - Founder/CEO
Location
Woburn, Canada
Founded
2023
Employees
3 employees
Looking for specific startups?
Try our free semantic startup search

100XBIO

Score: 48/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The company specializes in T-cell antigen specificity and sequencing analysis through proprietary technology that enhances the understanding of T-cell receptor diversity. This capability is crucial for advancing immunology research, immunotherapy development, and improving disease diagnosis and treatment outcomes.

100xbio.com300+
Founded 2023Woburn, Canada

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Sergei Pustylnikov

Founder/CEO

100XBIO | StartupSeeker